Sangamo Therapeutics Inc. (SGMO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sangamo Therapeutics Inc.

    NASDAQ: SGMO · Real-Time Price · USD
    0.53
    -0.02 (-3.14%)
    At close: Sep 08, 2025, 1:02 PM

    Sangamo Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 41.92M 45.2M 100.44M 178.87M
    Short-Term Investments
    		 n/a 35.8M 177.19M 197.68M
    Long-Term Investments
    		 1.5M 1.5M 29.84M 88.17M
    Other Long-Term Assets
    		 13.69M 16.63M 12.25M 10.17M
    Receivables
    		 4.6M 4.07M 4.47M 6.36M
    Inventory
    		 n/a n/a n/a -88.17M
    Other Current Assets
    		 5.17M 9.26M n/a 88.17M
    Total Current Assets
    		 51.69M 94.33M 300.33M 398.77M
    Property-Plant & Equipment
    		 34.76M 52.87M 125.53M 124.7M
    Goodwill & Intangibles
    		 n/a n/a 88.28M 93.46M
    Total Long-Term Assets
    		 49.94M 70.99M 262.18M 323.15M
    Total Assets
    		 101.64M 165.32M 562.51M 721.92M
    Account Payables
    		 15.48M 15.26M 22.42M 9.76M
    Deferred Revenue
    		 7.56M n/a 51.78M 85.71M
    Short-Term Debt
    		 n/a n/a n/a 4.03M
    Other Current Liabilities
    		 14.57M 11.73M 11.88M 3.52M
    Total Current Liabilities
    		 45.8M 47.73M 111.71M 127.89M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 933K 1.19M 1.21M 1.22M
    Total Long-Term Liabilities
    		 33.06M 34.7M 155.84M 218.69M
    Total Liabilities
    		 78.86M 82.43M 267.55M 346.58M
    Total Debt
    		 30.57M 38.1M 43.11M 48.08M
    Common Stock
    		 2.13M 1.78M 1.67M 1.46M
    Retained Earnings
    		 -1.5B -1.41B -1.15B -956.27M
    Comprehensive Income
    		 -7.53M -4.59M -8.4M -3.99M
    Shareholders Equity
    		 22.77M 82.89M 294.96M 375.34M
    Total Investments
    		 1.5M 35.8M 207.03M 285.85M

    Add to Watchlist